000 01537 a2200421 4500
005 20250512225656.0
264 0 _c19830826
008 198308s 0 0 eng d
022 _a0277-3732
024 7 _a10.1097/00000421-198308000-00001
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aLevitt, S H
245 0 0 _aMultimodal therapy in the treatment of breast cancer.
_h[electronic resource]
260 _bAmerican journal of clinical oncology
_cAug 1983
300 _a387-91 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAntineoplastic Agents
_xadministration & dosage
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
650 0 4 _aBreast Neoplasms
_xdrug therapy
650 0 4 _aCyclophosphamide
_xadministration & dosage
650 0 4 _aDrug Therapy, Combination
650 0 4 _aFemale
650 0 4 _aFluorouracil
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aLeukocyte Count
650 0 4 _aMethotrexate
_xadministration & dosage
650 0 4 _aPrednisone
_xadministration & dosage
650 0 4 _aPrognosis
650 0 4 _aRadiotherapy Dosage
650 0 4 _aRetrospective Studies
650 0 4 _aVincristine
_xadministration & dosage
700 1 _aKhan, F M
700 1 _aBoen, J R
700 1 _aPotish, R A
700 1 _aBowers, B J
773 0 _tAmerican journal of clinical oncology
_gvol. 6
_gno. 4
_gp. 387-91
856 4 0 _uhttps://doi.org/10.1097/00000421-198308000-00001
_zAvailable from publisher's website
999 _c6687941
_d6687941